Foldable Future
This carefully selected group of stocks represents companies at the forefront of the foldable phone revolution. With Samsung launching new AI-powered foldables including a budget option, these specialized component suppliers are positioned to benefit as this innovative technology goes mainstream.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Universal Display Corp.
OLED
Current price
$140.75
Develops and licenses patented OLED technologies and materials that are critical for the energy-efficient, flexible displays required in foldable phon...
Develops and licenses patented OLED technologies and materials that are critical for the energy-efficient, flexible displays required in foldable phones.
Corning Inc.
GLW
Current price
$64.52
As the manufacturer of Gorilla Glass and specialized ultra-thin glass (UTG), Corning is a primary supplier for the durable, flexible screens on foldab...
As the manufacturer of Gorilla Glass and specialized ultra-thin glass (UTG), Corning is a primary supplier for the durable, flexible screens on foldable devices.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
Samsung's introduction of more accessible folding phones signals a pivotal shift from niche to mainstream adoption. As foldable technology grows beyond early adopters, companies making the specialized components these devices require could see significant growth in demand for their high-margin products.
What You Need to Know
This theme focuses on the entire supply chain enabling foldable phones, from display manufacturers and glass specialists to semiconductor companies and equipment providers. These stocks represent upstream suppliers whose technology makes the foldable revolution possible rather than just consumer brands.
Why These Stocks
Our analysts have identified companies providing the essential technologies for foldable phones: flexible OLED displays, ultra-thin glass, specialized hinges, and AI-capable processors. These firms have established positions in a growing market as foldable devices become more affordable and widespread.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+19.24%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 19.24% over the next year.
Stocks Rated Buy by Analysts
13 of 15 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
The Fold Is Going Mainstream
Samsung's introduction of a budget-friendly foldable phone could be the catalyst that pushes this technology from niche to mainstream. As adoption grows, the companies making essential components stand to benefit significantly.
The Parts, Not Just The Phones
While everyone focuses on the finished phones, smart investors are looking at the specialized parts inside. These companies provide the unique displays, glass, hinges and chips that make folding phones possible.
Riding The Innovation Wave
Foldable phones represent a new growth cycle in mobile technology after years of similar-looking smartphones. These suppliers are positioned at the beginning of what could be a multi-year trend as the technology becomes more affordable.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.